Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfeb
|
ENSMUSG00000023990.12 | transcription factor EB |
Usf1
|
ENSMUSG00000026641.7 | upstream transcription factor 1 |
Srebf1
|
ENSMUSG00000020538.9 | sterol regulatory element binding transcription factor 1 |
Usf2
|
ENSMUSG00000058239.7 | upstream transcription factor 2 |
Bhlhe41
|
ENSMUSG00000030256.5 | basic helix-loop-helix family, member e41 |
Srebf2
|
ENSMUSG00000022463.7 | sterol regulatory element binding factor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_145866076_145866544 | Bhlhe41 | 752 | 0.610275 | -0.17 | 2.2e-01 | Click! |
chr6_145865429_145865982 | Bhlhe41 | 147 | 0.946647 | -0.04 | 8.0e-01 | Click! |
chr6_145885236_145885387 | Bhlhe41 | 19753 | 0.147517 | 0.03 | 8.1e-01 | Click! |
chr6_145871107_145871266 | Bhlhe41 | 5628 | 0.181557 | 0.03 | 8.2e-01 | Click! |
chr6_145866615_145866856 | Bhlhe41 | 1177 | 0.436863 | -0.03 | 8.5e-01 | Click! |
chr11_60219773_60219941 | Srebf1 | 747 | 0.519347 | 0.76 | 1.9e-11 | Click! |
chr11_60222704_60223385 | Srebf1 | 463 | 0.711618 | 0.68 | 8.6e-09 | Click! |
chr11_60220284_60221093 | Srebf1 | 84 | 0.949787 | 0.68 | 1.5e-08 | Click! |
chr11_60220024_60220206 | Srebf1 | 489 | 0.691985 | 0.63 | 2.8e-07 | Click! |
chr11_60222412_60222585 | Srebf1 | 83 | 0.950048 | 0.58 | 4.3e-06 | Click! |
chr15_82165538_82165693 | Srebf2 | 17590 | 0.085316 | 0.66 | 3.8e-08 | Click! |
chr15_82166278_82166429 | Srebf2 | 18328 | 0.084275 | 0.64 | 1.9e-07 | Click! |
chr15_82164544_82164745 | Srebf2 | 16619 | 0.086676 | 0.59 | 1.7e-06 | Click! |
chr15_82166504_82166655 | Srebf2 | 18554 | 0.083955 | 0.56 | 9.8e-06 | Click! |
chr15_82164219_82164441 | Srebf2 | 16305 | 0.087114 | 0.55 | 1.3e-05 | Click! |
chr17_47754107_47754296 | Tfeb | 125 | 0.938776 | 0.66 | 4.9e-08 | Click! |
chr17_47754318_47754507 | Tfeb | 86 | 0.951336 | 0.66 | 4.9e-08 | Click! |
chr17_47762144_47762313 | Tfeb | 942 | 0.447259 | 0.60 | 1.0e-06 | Click! |
chr17_47736882_47737931 | Tfeb | 194 | 0.894042 | 0.60 | 1.0e-06 | Click! |
chr17_47796284_47796454 | Tfeb | 6928 | 0.136335 | -0.56 | 9.9e-06 | Click! |
chr1_171412543_171412830 | Usf1 | 1005 | 0.312741 | -0.28 | 3.7e-02 | Click! |
chr1_171411228_171411411 | Usf1 | 6 | 0.944353 | 0.08 | 5.5e-01 | Click! |
chr1_171411494_171411879 | Usf1 | 5 | 0.944438 | 0.06 | 6.8e-01 | Click! |
chr1_171410906_171411189 | Usf1 | 266 | 0.806267 | -0.04 | 7.8e-01 | Click! |
chr1_171412046_171412381 | Usf1 | 532 | 0.571516 | 0.01 | 9.2e-01 | Click! |
chr7_30955937_30956673 | Usf2 | 66 | 0.794383 | 0.74 | 1.4e-10 | Click! |
chr7_30954142_30954471 | Usf2 | 1144 | 0.205993 | 0.54 | 1.9e-05 | Click! |
chr7_30953667_30953818 | Usf2 | 1708 | 0.138120 | 0.44 | 8.0e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 43.85 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr14_14354416_14355184 | 32.42 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr8_39152774_39153465 | 24.14 |
Gm20948 |
predicted gene, 20948 |
47930 |
0.13 |
chr10_127062800_127064205 | 17.31 |
Cdk4 |
cyclin-dependent kinase 4 |
32 |
0.93 |
chr1_152817059_152817770 | 14.95 |
Ncf2 |
neutrophil cytosolic factor 2 |
6155 |
0.16 |
chr13_99019003_99019175 | 14.93 |
A930014D07Rik |
RIKEN cDNA A930014D07 gene |
11990 |
0.12 |
chr2_101827257_101827423 | 14.20 |
Prr5l |
proline rich 5 like |
11640 |
0.22 |
chr3_104674079_104674236 | 13.87 |
Gm29560 |
predicted gene 29560 |
4147 |
0.11 |
chr10_121569006_121569830 | 13.83 |
Tbk1 |
TANK-binding kinase 1 |
937 |
0.48 |
chr8_94734148_94734373 | 13.50 |
Ccl22 |
chemokine (C-C motif) ligand 22 |
11330 |
0.12 |
chr11_117780269_117780842 | 13.40 |
Tmc6 |
transmembrane channel-like gene family 6 |
66 |
0.93 |
chr19_7240431_7241403 | 13.16 |
Naa40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
117 |
0.93 |
chr2_164832677_164833913 | 12.89 |
Neurl2 |
neuralized E3 ubiquitin protein ligase 2 |
161 |
0.69 |
chr13_63567343_63568686 | 12.28 |
A930032L01Rik |
RIKEN cDNA A930032L01 gene |
40 |
0.96 |
chr6_39423688_39423950 | 12.07 |
Gm25402 |
predicted gene, 25402 |
1400 |
0.3 |
chr10_94249569_94249879 | 11.85 |
Gm4792 |
predicted gene 4792 |
48979 |
0.1 |
chr8_13159108_13159452 | 11.75 |
Lamp1 |
lysosomal-associated membrane protein 1 |
119 |
0.93 |
chr6_52172131_52173085 | 11.47 |
Gm15050 |
predicted gene 15050 |
273 |
0.71 |
chr5_135001339_135001605 | 11.40 |
Wbscr25 |
Williams Beuren syndrome chromosome region 25 (human) |
122 |
0.9 |
chr3_103171228_103172264 | 11.35 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr4_155370873_155371057 | 11.26 |
Prkcz |
protein kinase C, zeta |
9604 |
0.13 |
chr11_69854050_69854225 | 11.24 |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
1465 |
0.14 |
chr6_52225788_52226610 | 10.88 |
Hoxa9 |
homeobox A9 |
10 |
0.91 |
chr12_8882517_8882706 | 10.86 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
5229 |
0.2 |
chr5_104046034_104046629 | 10.79 |
Nudt9 |
nudix (nucleoside diphosphate linked moiety X)-type motif 9 |
25 |
0.93 |
chr9_41073622_41073978 | 10.77 |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
5706 |
0.19 |
chr1_13660088_13660745 | 10.74 |
Lactb2 |
lactamase, beta 2 |
130 |
0.96 |
chr17_88466951_88467102 | 10.69 |
Foxn2 |
forkhead box N2 |
26251 |
0.16 |
chr2_172441267_172441429 | 10.55 |
Rtf2 |
replication termination factor 2 |
746 |
0.38 |
chr18_20611245_20611418 | 10.41 |
Dsg2 |
desmoglein 2 |
53085 |
0.09 |
chr8_108990543_108990891 | 10.38 |
Mir3108 |
microRNA 3108 |
53857 |
0.14 |
chr7_90129639_90130990 | 10.22 |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
21 |
0.82 |
chr15_76697423_76698657 | 10.04 |
Gpt |
glutamic pyruvic transaminase, soluble |
22 |
0.93 |
chr11_31824301_31824782 | 10.03 |
D630024D03Rik |
RIKEN cDNA D630024D03 gene |
17 |
0.98 |
chr11_96286481_96286660 | 10.02 |
Hoxb7 |
homeobox B7 |
53 |
0.92 |
chr2_35610268_35610691 | 9.99 |
Dab2ip |
disabled 2 interacting protein |
11502 |
0.2 |
chr7_16310401_16311417 | 9.94 |
Bbc3 |
BCL2 binding component 3 |
454 |
0.72 |
chr5_36726254_36726643 | 9.94 |
Gm43701 |
predicted gene 43701 |
22170 |
0.11 |
chr3_30766243_30766492 | 9.91 |
Samd7 |
sterile alpha motif domain containing 7 |
10145 |
0.14 |
chr16_92466174_92466763 | 9.71 |
Rcan1 |
regulator of calcineurin 1 |
322 |
0.85 |
chr11_31830043_31830943 | 9.69 |
Gm12107 |
predicted gene 12107 |
2167 |
0.31 |
chr4_128654325_128654785 | 9.69 |
Phc2 |
polyhomeotic 2 |
147 |
0.95 |
chr13_52060460_52060782 | 9.50 |
Gm48190 |
predicted gene, 48190 |
36021 |
0.14 |
chr5_139695003_139695332 | 9.47 |
Gm42424 |
predicted gene 42424 |
6480 |
0.17 |
chr18_54990870_54991544 | 9.40 |
Gm4221 |
predicted gene 4221 |
897 |
0.44 |
chr2_73093042_73093445 | 9.34 |
Gm13665 |
predicted gene 13665 |
23505 |
0.16 |
chr5_112324889_112325204 | 9.34 |
Tfip11 |
tuftelin interacting protein 11 |
1312 |
0.28 |
chr6_29467899_29468607 | 9.13 |
Atp6v1f |
ATPase, H+ transporting, lysosomal V1 subunit F |
185 |
0.89 |
chr10_80081115_80081433 | 9.04 |
Sbno2 |
strawberry notch 2 |
5835 |
0.1 |
chr10_118803985_118804150 | 9.02 |
Gm4065 |
predicted gene 4065 |
1192 |
0.44 |
chr4_80949710_80950052 | 8.95 |
Gm27452 |
predicted gene, 27452 |
17563 |
0.24 |
chr1_84851830_84852040 | 8.91 |
Trip12 |
thyroid hormone receptor interactor 12 |
11419 |
0.14 |
chr13_100517825_100518211 | 8.78 |
Gtf2h2 |
general transcription factor II H, polypeptide 2 |
25439 |
0.11 |
chr6_54866910_54867061 | 8.71 |
Gm44185 |
predicted gene, 44185 |
35437 |
0.15 |
chr16_94569391_94569773 | 8.66 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
428 |
0.84 |
chr17_80131930_80132097 | 8.65 |
Galm |
galactose mutarotase |
4542 |
0.18 |
chr16_30969110_30969627 | 8.60 |
Gm15742 |
predicted gene 15742 |
4150 |
0.22 |
chr11_44508913_44509245 | 8.59 |
Rnf145 |
ring finger protein 145 |
9885 |
0.16 |
chr6_116337548_116338523 | 8.54 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
1 |
0.56 |
chr15_95849699_95850030 | 8.46 |
Gm17546 |
predicted gene, 17546 |
19792 |
0.14 |
chr16_30045625_30045837 | 8.45 |
9030404E10Rik |
RIKEN cDNA 9030404E10 gene |
6252 |
0.16 |
chr5_90488243_90488741 | 8.40 |
Afp |
alpha fetoprotein |
2245 |
0.23 |
chr4_44253300_44253543 | 8.33 |
Rnf38 |
ring finger protein 38 |
19632 |
0.15 |
chr1_77267443_77267611 | 8.33 |
Epha4 |
Eph receptor A4 |
110080 |
0.06 |
chr2_166805449_166805678 | 8.32 |
Arfgef2 |
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) |
25 |
0.97 |
chr3_116562756_116563068 | 8.20 |
Lrrc39 |
leucine rich repeat containing 39 |
61 |
0.93 |
chr2_48949106_48950119 | 8.20 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr12_3238356_3238681 | 8.19 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
1907 |
0.28 |
chr1_74713121_74713297 | 8.16 |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
365 |
0.81 |
chr17_47175016_47175172 | 8.14 |
Trerf1 |
transcriptional regulating factor 1 |
33878 |
0.17 |
chr11_120633520_120633920 | 8.13 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
120 |
0.87 |
chr19_27218787_27219206 | 8.08 |
Vldlr |
very low density lipoprotein receptor |
1538 |
0.41 |
chr8_123736966_123737350 | 8.06 |
Gm45781 |
predicted gene 45781 |
2016 |
0.14 |
chr13_103774154_103774336 | 8.03 |
Srek1 |
splicing regulatory glutamine/lysine-rich protein 1 |
152 |
0.97 |
chr17_47059715_47060190 | 7.97 |
Gm4945 |
predicted gene 4945 |
16913 |
0.17 |
chr5_103709198_103709360 | 7.89 |
Aff1 |
AF4/FMR2 family, member 1 |
16905 |
0.17 |
chr11_96344075_96344719 | 7.88 |
Hoxb3 |
homeobox B3 |
628 |
0.45 |
chr8_83215285_83215455 | 7.88 |
Tbc1d9 |
TBC1 domain family, member 9 |
43889 |
0.11 |
chr5_137509990_137510312 | 7.87 |
Gm8066 |
predicted gene 8066 |
102 |
0.91 |
chr5_115010914_115011989 | 7.83 |
Sppl3 |
signal peptide peptidase 3 |
46 |
0.95 |
chr17_73034947_73035138 | 7.82 |
Gm30420 |
predicted gene, 30420 |
5964 |
0.24 |
chr10_111164274_111164899 | 7.80 |
Osbpl8 |
oxysterol binding protein-like 8 |
166 |
0.93 |
chr15_12194878_12195029 | 7.79 |
Gm49240 |
predicted gene, 49240 |
1666 |
0.23 |
chr5_117360274_117360464 | 7.77 |
Wsb2 |
WD repeat and SOCS box-containing 2 |
653 |
0.55 |
chr6_94093093_94093244 | 7.77 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
179478 |
0.03 |
chr11_109350386_109350688 | 7.77 |
1700096J18Rik |
RIKEN cDNA 1700096J18 gene |
3698 |
0.17 |
chr3_108751136_108751472 | 7.74 |
Aknad1 |
AKNA domain containing 1 |
1222 |
0.4 |
chr7_101905477_101905971 | 7.73 |
Lamtor1 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 |
180 |
0.78 |
chr11_87709834_87710267 | 7.72 |
1110028F11Rik |
RIKEN cDNA 1110028F11 gene |
7927 |
0.1 |
chr11_52000581_52000992 | 7.70 |
Ube2b |
ubiquitin-conjugating enzyme E2B |
24 |
0.53 |
chr4_10924249_10924462 | 7.66 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
22253 |
0.14 |
chr2_164457860_164458168 | 7.65 |
Sys1 |
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) |
926 |
0.32 |
chr10_128923395_128923597 | 7.57 |
Bloc1s1 |
biogenesis of lysosomal organelles complex-1, subunit 1 |
28 |
0.89 |
chr5_115531647_115532302 | 7.57 |
Pxn |
paxillin |
10940 |
0.09 |
chr5_122274832_122275061 | 7.54 |
Pptc7 |
PTC7 protein phosphatase homolog |
9419 |
0.11 |
chr17_22361319_22361509 | 7.50 |
Zfp944 |
zinc finger protein 944 |
14 |
0.51 |
chr12_85532591_85532965 | 7.50 |
Gm32296 |
predicted gene, 32296 |
3180 |
0.23 |
chr17_28517452_28517911 | 7.49 |
Fkbp5 |
FK506 binding protein 5 |
154 |
0.87 |
chr5_122602364_122602555 | 7.46 |
Ift81 |
intraflagellar transport 81 |
1034 |
0.42 |
chr11_102881127_102881593 | 7.46 |
Ccdc103 |
coiled-coil domain containing 103 |
115 |
0.77 |
chr7_29338673_29338824 | 7.42 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
315 |
0.84 |
chr5_31968296_31968539 | 7.39 |
Gm43811 |
predicted gene 43811 |
41720 |
0.14 |
chr1_191821554_191822025 | 7.39 |
Gm38037 |
predicted gene, 38037 |
204 |
0.58 |
chr7_81687999_81688179 | 7.38 |
Homer2 |
homer scaffolding protein 2 |
4798 |
0.15 |
chr17_46004292_46004515 | 7.38 |
Vegfa |
vascular endothelial growth factor A |
16969 |
0.16 |
chr15_79833949_79834578 | 7.37 |
Cbx6 |
chromobox 6 |
11 |
0.5 |
chr11_96935069_96935551 | 7.36 |
Prr15l |
proline rich 15-like |
3923 |
0.1 |
chr12_102878344_102878853 | 7.36 |
Btbd7 |
BTB (POZ) domain containing 7 |
127 |
0.94 |
chr15_96455910_96456125 | 7.34 |
Scaf11 |
SR-related CTD-associated factor 11 |
4783 |
0.23 |
chr5_66112077_66112228 | 7.32 |
Rbm47 |
RNA binding motif protein 47 |
13961 |
0.12 |
chr17_42885097_42885294 | 7.32 |
Cd2ap |
CD2-associated protein |
8530 |
0.29 |
chr8_41239412_41240485 | 7.31 |
Pcm1 |
pericentriolar material 1 |
170 |
0.95 |
chr13_97825475_97826241 | 7.30 |
Gm41031 |
predicted gene, 41031 |
27 |
0.98 |
chr6_52204413_52204627 | 7.28 |
Hoxa5 |
homeobox A5 |
67 |
0.89 |
chr18_61953800_61953987 | 7.28 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
809 |
0.64 |
chr6_90707207_90707417 | 7.28 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
9217 |
0.16 |
chr1_36272382_36272841 | 7.21 |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
824 |
0.56 |
chr5_123057752_123058346 | 7.20 |
Gm6444 |
predicted gene 6444 |
8193 |
0.09 |
chr6_72097140_72098281 | 7.13 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr18_82568393_82568575 | 7.12 |
Mbp |
myelin basic protein |
5222 |
0.19 |
chr10_24634332_24634557 | 7.12 |
Gm15270 |
predicted gene 15270 |
37336 |
0.13 |
chr1_165769277_165769456 | 7.07 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
110 |
0.93 |
chr4_150745963_150746359 | 7.06 |
Gm16079 |
predicted gene 16079 |
67369 |
0.09 |
chr9_40638047_40638611 | 6.96 |
Gm48284 |
predicted gene, 48284 |
21943 |
0.1 |
chr2_18671841_18672581 | 6.95 |
Commd3 |
COMM domain containing 3 |
173 |
0.93 |
chr1_87326740_87327750 | 6.94 |
Gigyf2 |
GRB10 interacting GYF protein 2 |
179 |
0.92 |
chr19_38026271_38026463 | 6.94 |
Myof |
myoferlin |
16984 |
0.15 |
chr16_32487939_32488112 | 6.91 |
Slc51a |
solute carrier family 51, alpha subunit |
146 |
0.93 |
chr3_84883956_84884121 | 6.89 |
Gm37726 |
predicted gene, 37726 |
10147 |
0.24 |
chr1_152766000_152766716 | 6.88 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
7 |
0.7 |
chr19_53185007_53185181 | 6.88 |
Add3 |
adducin 3 (gamma) |
3498 |
0.2 |
chrX_142778827_142779023 | 6.83 |
Gm15049 |
predicted gene 15049 |
2578 |
0.28 |
chr11_96943726_96944317 | 6.83 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
35 |
0.62 |
chr10_41518974_41519381 | 6.82 |
Cd164 |
CD164 antigen |
237 |
0.88 |
chr11_96303094_96303989 | 6.82 |
Hoxb5 |
homeobox B5 |
29 |
0.92 |
chr1_162815850_162816013 | 6.80 |
Fmo4 |
flavin containing monooxygenase 4 |
1959 |
0.32 |
chr11_86358219_86358558 | 6.80 |
Med13 |
mediator complex subunit 13 |
786 |
0.67 |
chr8_11477790_11477962 | 6.78 |
E230013L22Rik |
RIKEN cDNA E230013L22 gene |
53 |
0.93 |
chr8_106136769_106137557 | 6.76 |
1810019D21Rik |
RIKEN cDNA 1810019D21 gene |
98 |
0.62 |
chr9_106367425_106368835 | 6.74 |
Dusp7 |
dual specificity phosphatase 7 |
502 |
0.7 |
chr7_118756592_118756841 | 6.74 |
Vps35l |
VPS35 endosomal protein sorting factor like |
4053 |
0.14 |
chr6_34471573_34471731 | 6.74 |
Bpgm |
2,3-bisphosphoglycerate mutase |
4555 |
0.19 |
chr1_185515526_185516243 | 6.73 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
18496 |
0.17 |
chr11_88999276_88999500 | 6.72 |
Trim25 |
tripartite motif-containing 25 |
12 |
0.96 |
chr6_143142224_143142402 | 6.70 |
Gm44306 |
predicted gene, 44306 |
7226 |
0.14 |
chr14_63130761_63130912 | 6.70 |
Ctsb |
cathepsin B |
4682 |
0.15 |
chr17_29503456_29503607 | 6.68 |
Pim1 |
proviral integration site 1 |
10124 |
0.1 |
chr5_124605361_124605521 | 6.68 |
Tctn2 |
tectonic family member 2 |
6644 |
0.12 |
chr11_119392977_119393557 | 6.68 |
Rnf213 |
ring finger protein 213 |
167 |
0.93 |
chr15_84672710_84672866 | 6.66 |
Prr5 |
proline rich 5 (renal) |
3168 |
0.25 |
chr16_92494535_92494840 | 6.62 |
Clic6 |
chloride intracellular channel 6 |
3447 |
0.19 |
chr13_111940877_111941182 | 6.62 |
Gm15322 |
predicted gene 15322 |
50437 |
0.1 |
chr11_54958733_54958898 | 6.61 |
Tnip1 |
TNFAIP3 interacting protein 1 |
2693 |
0.22 |
chr3_79842151_79842463 | 6.57 |
Tmem144 |
transmembrane protein 144 |
372 |
0.85 |
chr8_33927476_33927764 | 6.57 |
Rbpms |
RNA binding protein gene with multiple splicing |
1656 |
0.35 |
chr11_69097394_69097796 | 6.56 |
Per1 |
period circadian clock 1 |
1353 |
0.2 |
chr8_108901327_108901478 | 6.49 |
Gm20686 |
predicted gene 20686 |
20472 |
0.19 |
chr3_152396134_152396493 | 6.47 |
Zzz3 |
zinc finger, ZZ domain containing 3 |
181 |
0.9 |
chr12_101025485_101025716 | 6.46 |
Ccdc88c |
coiled-coil domain containing 88C |
3309 |
0.15 |
chr10_115362334_115363051 | 6.43 |
Tmem19 |
transmembrane protein 19 |
191 |
0.92 |
chr15_7931542_7931873 | 6.41 |
Rpl19-ps6 |
ribosomal protein L19, pseudogene 6 |
43368 |
0.13 |
chr12_55487261_55487601 | 6.40 |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
4379 |
0.2 |
chr17_46864820_46864971 | 6.35 |
Bicral |
BRD4 interacting chromatin remodeling complex associated protein like |
6413 |
0.16 |
chr14_67608396_67608547 | 6.35 |
Gm47010 |
predicted gene, 47010 |
19679 |
0.17 |
chr4_140620651_140620811 | 6.32 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
3666 |
0.23 |
chr18_61665433_61665940 | 6.29 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
149 |
0.92 |
chr11_98941353_98942362 | 6.28 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chr11_3931902_3932189 | 6.27 |
Tcn2 |
transcobalamin 2 |
1 |
0.95 |
chr9_108338578_108339700 | 6.27 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr17_34898151_34899707 | 6.20 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr3_153905538_153906361 | 6.17 |
Msh4 |
mutS homolog 4 |
189 |
0.87 |
chr11_11461889_11462101 | 6.16 |
Spata48 |
spermatogenesis associated 48 |
99 |
0.83 |
chr8_25772876_25773027 | 6.15 |
Bag4 |
BCL2-associated athanogene 4 |
4631 |
0.11 |
chr14_73106935_73107379 | 6.14 |
Rcbtb2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
15880 |
0.2 |
chr14_63272981_63273156 | 6.14 |
Gata4 |
GATA binding protein 4 |
1376 |
0.41 |
chr11_84513465_84514047 | 6.11 |
Aatf |
apoptosis antagonizing transcription factor |
234 |
0.93 |
chr17_29393375_29393526 | 6.10 |
Fgd2 |
FYVE, RhoGEF and PH domain containing 2 |
16949 |
0.11 |
chr5_113975956_113976160 | 6.09 |
Ssh1 |
slingshot protein phosphatase 1 |
9302 |
0.13 |
chr15_79030528_79031002 | 6.09 |
Gcat |
glycine C-acetyltransferase (2-amino-3-ketobutyrate-coenzyme A ligase) |
109 |
0.89 |
chr13_99100048_99100764 | 6.06 |
Gm807 |
predicted gene 807 |
300 |
0.89 |
chr11_61683979_61684176 | 6.06 |
Fam83g |
family with sequence similarity 83, member G |
14 |
0.97 |
chr19_4059281_4059805 | 6.04 |
Gstp3 |
glutathione S-transferase pi 3 |
26 |
0.92 |
chr2_128278806_128279000 | 6.01 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
37096 |
0.18 |
chr1_75142553_75142855 | 6.01 |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
7 |
0.54 |
chr3_137968882_137969042 | 6.00 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12568 |
0.12 |
chr5_107880813_107880988 | 5.97 |
Evi5 |
ecotropic viral integration site 5 |
5793 |
0.11 |
chr19_18644190_18644356 | 5.95 |
Nmrk1 |
nicotinamide riboside kinase 1 |
12275 |
0.15 |
chr6_52158050_52159133 | 5.94 |
Hotairm1 |
Hoxa transcript antisense RNA, myeloid-specific 1 |
67 |
0.73 |
chr17_88432076_88432239 | 5.94 |
Foxn2 |
forkhead box N2 |
8554 |
0.19 |
chr3_135628675_135628826 | 5.93 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
6608 |
0.2 |
chr6_125256686_125256837 | 5.90 |
Gm44259 |
predicted gene, 44259 |
1247 |
0.19 |
chr4_15958129_15958823 | 5.90 |
Nbn |
nibrin |
509 |
0.69 |
chr11_59238914_59239191 | 5.88 |
Arf1 |
ADP-ribosylation factor 1 |
10782 |
0.1 |
chr11_84442587_84442829 | 5.86 |
Aatf |
apoptosis antagonizing transcription factor |
6825 |
0.26 |
chr9_121313990_121314380 | 5.86 |
Trak1 |
trafficking protein, kinesin binding 1 |
53 |
0.97 |
chr9_113833592_113833892 | 5.86 |
Clasp2 |
CLIP associating protein 2 |
21142 |
0.2 |
chr2_11457969_11458120 | 5.85 |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
24067 |
0.11 |
chr13_60674881_60675258 | 5.84 |
Dapk1 |
death associated protein kinase 1 |
21344 |
0.15 |
chr11_117781964_117782405 | 5.84 |
Tmc6 |
transmembrane channel-like gene family 6 |
14 |
0.58 |
chr9_107618718_107619189 | 5.84 |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
1481 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
3.9 | 3.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
3.8 | 15.1 | GO:0010288 | response to lead ion(GO:0010288) |
3.1 | 9.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
3.0 | 9.1 | GO:0015889 | cobalamin transport(GO:0015889) |
3.0 | 9.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.7 | 8.2 | GO:0032439 | endosome localization(GO:0032439) |
2.6 | 10.2 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
2.4 | 7.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.4 | 7.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
2.3 | 7.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
2.3 | 6.8 | GO:0060435 | bronchiole development(GO:0060435) |
2.2 | 8.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.1 | 10.7 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
2.1 | 4.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.1 | 8.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
2.0 | 3.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.9 | 5.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.9 | 5.7 | GO:0036166 | phenotypic switching(GO:0036166) |
1.8 | 5.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.8 | 7.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.8 | 7.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.8 | 5.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.8 | 5.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.7 | 5.2 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.7 | 5.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.7 | 8.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.7 | 3.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.6 | 4.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.6 | 8.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.6 | 4.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.6 | 6.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.5 | 4.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.5 | 6.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.5 | 4.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.5 | 4.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.5 | 7.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.5 | 4.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.5 | 10.2 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
1.5 | 4.4 | GO:1902896 | terminal web assembly(GO:1902896) |
1.4 | 2.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.4 | 4.2 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
1.4 | 5.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.4 | 4.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.4 | 10.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.4 | 5.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.3 | 9.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.3 | 1.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.3 | 5.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.3 | 3.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 5.1 | GO:0019532 | oxalate transport(GO:0019532) |
1.3 | 2.5 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.3 | 3.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.2 | 3.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.2 | 7.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.2 | 3.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.2 | 4.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.2 | 3.6 | GO:0036394 | amylase secretion(GO:0036394) |
1.2 | 3.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.2 | 3.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.2 | 3.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
1.2 | 10.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.2 | 1.2 | GO:0032252 | secretory granule localization(GO:0032252) |
1.2 | 3.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.1 | 3.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.1 | 5.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.1 | 2.2 | GO:0072718 | response to cisplatin(GO:0072718) |
1.1 | 4.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 3.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.1 | 4.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.1 | 2.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
1.1 | 5.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.1 | 2.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
1.1 | 5.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.1 | 4.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.1 | 5.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
1.1 | 2.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.1 | 5.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.0 | 3.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.0 | 6.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.0 | 3.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.0 | 6.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.0 | 8.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.0 | 8.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.0 | 4.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.0 | 3.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.0 | 4.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.0 | 9.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.0 | 6.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.0 | 3.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.0 | 5.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.0 | 3.9 | GO:0072040 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
1.0 | 7.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.0 | 2.9 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.9 | 5.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.9 | 5.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.9 | 4.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.9 | 7.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.9 | 8.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.9 | 2.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.9 | 2.8 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 0.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.9 | 4.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.9 | 1.9 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.9 | 1.9 | GO:1903306 | negative regulation of exocytosis(GO:0045920) negative regulation of regulated secretory pathway(GO:1903306) |
0.9 | 3.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.9 | 1.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.9 | 1.8 | GO:0061724 | lipophagy(GO:0061724) |
0.9 | 2.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.9 | 6.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.9 | 2.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.9 | 5.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.9 | 8.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.9 | 1.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.9 | 2.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 4.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.9 | 10.3 | GO:0007614 | short-term memory(GO:0007614) |
0.9 | 1.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.8 | 12.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.8 | 0.8 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.8 | 2.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.8 | 2.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 0.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 2.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.8 | 2.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.8 | 1.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 2.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.8 | 0.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.8 | 3.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.8 | 4.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.8 | 3.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.8 | 1.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.8 | 12.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 3.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.8 | 4.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 1.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.8 | 0.8 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.8 | 1.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 4.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.8 | 6.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 0.8 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.8 | 2.3 | GO:0032264 | IMP salvage(GO:0032264) |
0.8 | 2.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.8 | 2.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.8 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 2.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 5.3 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.8 | 3.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.8 | 6.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 2.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.7 | 3.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.7 | 2.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.7 | 3.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 5.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.7 | 1.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.7 | 12.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.7 | 2.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.7 | 7.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.7 | 5.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.7 | 2.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.7 | 8.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.7 | 1.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.7 | 3.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 5.7 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.7 | 2.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 5.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.7 | 2.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.7 | 12.6 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.7 | 3.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 1.4 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 9.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.7 | 4.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.7 | 4.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.7 | 2.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.7 | 2.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.7 | 7.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.7 | 2.0 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.7 | 9.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.7 | 3.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.7 | 7.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.7 | 0.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.7 | 3.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.7 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.7 | 2.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 0.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.7 | 2.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.7 | 3.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.7 | 1.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.7 | 1.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.7 | 1.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.6 | 0.6 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.6 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.3 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.6 | 3.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 2.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.6 | 3.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.6 | 0.6 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 3.8 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.6 | 1.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 1.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 2.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 3.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.6 | 1.9 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.6 | 1.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 1.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.6 | 9.8 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.6 | 0.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.6 | 1.8 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.6 | 1.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 2.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 1.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.6 | 1.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.6 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 1.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 1.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.6 | 1.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 3.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.6 | 4.7 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 1.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.6 | 5.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.6 | 1.8 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.6 | 1.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.6 | 1.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.6 | 2.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 1.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.6 | 2.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.6 | 7.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.6 | 0.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.6 | 6.4 | GO:0030220 | platelet formation(GO:0030220) |
0.6 | 1.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 0.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.6 | 2.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.6 | 2.3 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
0.6 | 1.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 1.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.6 | 1.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 0.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 11.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.6 | 6.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.6 | 1.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.6 | 2.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.6 | 2.8 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 3.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.6 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 2.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 5.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 1.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.5 | 3.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 1.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.5 | 1.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 2.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 0.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.5 | 2.7 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 0.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 1.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.5 | 1.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 4.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.5 | 2.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 0.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.5 | 1.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.5 | 0.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.5 | 2.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 1.6 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 3.6 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.5 | 2.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 2.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 7.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.5 | 1.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 1.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 2.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 2.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 2.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 2.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 1.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.5 | 1.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.5 | 8.5 | GO:0006298 | mismatch repair(GO:0006298) |
0.5 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 2.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.5 | 1.0 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 5.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.5 | 1.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 1.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.5 | 1.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 1.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 1.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 1.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 2.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 1.9 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.5 | 1.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 1.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 1.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.5 | 1.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 1.4 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.5 | 1.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.5 | 4.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.5 | 0.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 0.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) |
0.5 | 4.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 1.4 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.5 | 1.4 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 1.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 1.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 2.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 6.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 2.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 2.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.5 | 0.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.5 | 1.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.5 | 7.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.5 | 0.9 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.5 | 1.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.5 | 2.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 6.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.5 | 4.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.5 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 4.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 1.8 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 2.2 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.4 | 2.7 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 0.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 3.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 3.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 3.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 4.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 4.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 0.9 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 1.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.4 | 2.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 13.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 0.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.4 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 2.2 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 2.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 2.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 0.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 2.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 1.3 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.4 | 1.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.4 | 1.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.4 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 2.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 2.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.4 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.8 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.4 | 4.1 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.4 | 1.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 2.5 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.4 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 1.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.4 | 0.8 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.4 | 0.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 0.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.4 | 0.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 1.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 2.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 3.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.4 | 3.2 | GO:0043084 | penile erection(GO:0043084) |
0.4 | 2.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 0.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.4 | 1.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 4.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 0.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 0.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 1.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 1.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 3.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.4 | 3.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 2.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 1.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 7.7 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.4 | 0.8 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 1.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 0.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.4 | 4.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.4 | 2.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 10.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.4 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 0.7 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 0.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 1.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 0.7 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.4 | 1.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 5.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.4 | 1.5 | GO:1901660 | calcium ion export(GO:1901660) |
0.4 | 0.4 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.4 | 4.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.4 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 0.7 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.4 | 1.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.4 | 0.4 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.4 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 1.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 0.7 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 0.4 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 4.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 0.4 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.4 | 1.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 1.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 0.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 1.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 2.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 1.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 2.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 1.4 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 1.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 2.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.7 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.3 | 0.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.3 | 1.0 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 1.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 0.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 2.0 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.3 | 1.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 2.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 0.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 7.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 1.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 2.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 1.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 4.3 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.3 | 2.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.3 | 1.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 1.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 1.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 1.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.3 | 1.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 3.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 2.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 2.9 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 6.5 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.3 | 1.3 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.3 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 1.9 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.3 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 4.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 3.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 2.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 1.3 | GO:0051292 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.3 | 0.3 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 1.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 0.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 1.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 5.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 1.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 0.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.3 | 1.9 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 0.9 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.9 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 1.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 0.6 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) positive regulation of thyroid hormone generation(GO:2000611) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 3.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.3 | 4.0 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 0.9 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 4.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 4.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 1.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 3.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 0.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 0.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 2.1 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.3 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.9 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 2.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 2.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.3 | 0.6 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 0.6 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
0.3 | 0.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.3 | 5.8 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 0.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 0.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 0.9 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 5.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.6 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 1.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 2.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 1.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.6 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 0.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.3 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 0.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 0.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 1.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 4.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.3 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 0.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 1.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 3.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.8 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.3 | 3.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 1.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.3 | 0.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.3 | 2.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.3 | 1.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 11.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 3.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 11.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 2.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 1.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 1.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 0.5 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 1.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 1.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 0.8 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.3 | 0.8 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.3 | 0.8 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.3 | 2.9 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.3 | 1.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 1.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.8 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 2.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 7.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 0.5 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.5 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 1.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 2.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.3 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 2.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 2.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 0.5 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 1.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.3 | 1.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 7.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 0.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 1.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 1.7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.5 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 1.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.7 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.2 | 0.2 | GO:0006971 | hypotonic response(GO:0006971) |
0.2 | 0.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 1.2 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.2 | 1.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 1.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.2 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 2.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 2.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 6.1 | GO:0006885 | regulation of pH(GO:0006885) |
0.2 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 1.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.9 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 1.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 1.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.5 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.2 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 1.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 6.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 6.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 2.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 3.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 12.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 0.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.2 | 1.1 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 3.2 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 1.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 1.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 2.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 5.8 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.5 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 1.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.7 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 2.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 2.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.4 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.9 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.2 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 3.0 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 1.3 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.6 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.2 | 0.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 1.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 7.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.4 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.8 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.4 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.2 | 0.4 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.2 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 1.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 3.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.2 | 3.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.6 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 4.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 1.0 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.4 | GO:0044778 | meiotic cell cycle checkpoint(GO:0033313) meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.2 | 0.4 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 1.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 1.4 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 0.8 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.6 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.4 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 1.0 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.4 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 0.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.6 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 1.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 0.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 2.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 1.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 1.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 1.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.4 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.2 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 2.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 11.5 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.2 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) positive regulation of response to drug(GO:2001025) |
0.2 | 0.2 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.2 | 0.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.6 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.2 | 0.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.2 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 1.8 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.2 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.4 | GO:0071864 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.2 | 0.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.9 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 4.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 1.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 2.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 0.5 | GO:0010885 | regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
0.2 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 1.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 2.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.2 | 0.2 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.2 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.2 | 0.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.2 | 1.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 2.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.4 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 1.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 2.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.2 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.2 | 0.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.7 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.4 | GO:0031100 | organ regeneration(GO:0031100) |
0.2 | 1.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 1.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.2 | 0.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 1.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.5 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 0.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.5 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 1.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.2 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 0.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 1.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.2 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.3 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.2 | 0.7 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.2 | 2.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 1.8 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.2 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 3.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 1.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.2 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.6 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 1.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.8 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.5 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.5 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 1.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.6 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 0.6 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.2 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.2 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.2 | 1.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 4.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 1.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.3 | GO:0031497 | chromatin assembly(GO:0031497) |
0.2 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.2 | 1.4 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 3.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 7.8 | GO:0006869 | lipid transport(GO:0006869) |
0.2 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.2 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 1.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 1.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 1.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 6.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.7 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 4.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 1.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 1.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 1.7 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 3.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.1 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 2.0 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 2.9 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.1 | 1.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 1.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 1.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 1.1 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 1.0 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 1.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.4 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.1 | GO:0060795 | cell fate commitment involved in formation of primary germ layer(GO:0060795) |
0.1 | 0.4 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 2.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.1 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.1 | 0.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.4 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 1.3 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 2.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.8 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 1.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.0 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.6 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 1.4 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.3 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.1 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.6 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 2.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 2.0 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 3.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 2.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 2.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.2 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.1 | 1.8 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 1.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.1 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 3.8 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.3 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 1.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 4.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 2.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.2 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.1 | 0.2 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 1.1 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.2 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 1.4 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0045911 | positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
0.1 | 0.1 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.8 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 4.0 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 7.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.2 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.2 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.3 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 4.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.5 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.2 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.6 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 1.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.7 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.6 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.6 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 1.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.6 | GO:0051904 | pigment granule transport(GO:0051904) |
0.1 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.1 | GO:0034032 | coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.1 | 0.5 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.2 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.2 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.1 | 0.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.2 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.1 | 0.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 3.3 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 0.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.1 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.1 | 1.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.9 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.4 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 1.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 1.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.9 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 6.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.5 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 1.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.1 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 1.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 1.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.4 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.1 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.2 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.8 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.6 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.1 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.1 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.4 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.1 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.1 | 0.4 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.4 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.1 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 4.0 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 1.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 0.8 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.4 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 3.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.2 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 1.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 2.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:2000345 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) regulation of hepatocyte proliferation(GO:2000345) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.1 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.6 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.4 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0016233 | telomere capping(GO:0016233) |
0.1 | 0.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.1 | GO:0060547 | negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
0.1 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.5 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.5 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.3 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
0.1 | 0.2 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.1 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 0.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 1.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 1.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 1.4 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0032655 | regulation of interleukin-12 production(GO:0032655) |
0.0 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.3 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.2 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.0 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.2 | GO:0042159 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
0.0 | 4.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.4 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.0 | 0.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 1.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.0 | 0.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.7 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 0.1 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.0 | 0.1 | GO:2000278 | regulation of DNA biosynthetic process(GO:2000278) |
0.0 | 0.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:0061217 | regulation of mesonephros development(GO:0061217) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0046635 | positive regulation of alpha-beta T cell activation(GO:0046635) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.3 | GO:0048771 | tissue remodeling(GO:0048771) |
0.0 | 0.0 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.0 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.0 | 0.8 | GO:0072331 | signal transduction by p53 class mediator(GO:0072331) |
0.0 | 0.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.2 | GO:0006323 | DNA packaging(GO:0006323) |
0.0 | 0.0 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.0 | 0.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.0 | 0.0 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 4.1 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 4.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.2 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:1990182 | exosomal secretion(GO:1990182) |
0.0 | 0.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.3 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.0 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.4 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.1 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.0 | 0.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.0 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.2 | GO:0071826 | ribonucleoprotein complex subunit organization(GO:0071826) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:1903707 | negative regulation of hemopoiesis(GO:1903707) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.0 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.2 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 1.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 12.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0021610 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
3.7 | 11.2 | GO:0032010 | phagolysosome(GO:0032010) |
3.2 | 9.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.4 | 9.5 | GO:0030891 | VCB complex(GO:0030891) |
2.0 | 5.9 | GO:0097413 | Lewy body(GO:0097413) |
1.9 | 7.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.7 | 5.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.7 | 11.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.7 | 5.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.6 | 1.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.5 | 7.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.4 | 5.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.4 | 8.3 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.4 | 18.9 | GO:0000974 | Prp19 complex(GO:0000974) |
1.3 | 14.4 | GO:0035102 | PRC1 complex(GO:0035102) |
1.3 | 6.5 | GO:0030870 | Mre11 complex(GO:0030870) |
1.3 | 5.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.2 | 7.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.1 | 4.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 3.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.1 | 4.4 | GO:0000938 | GARP complex(GO:0000938) |
1.1 | 5.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.1 | 2.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.1 | 3.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.1 | 4.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.0 | 5.2 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 6.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 6.1 | GO:0016589 | NURF complex(GO:0016589) |
1.0 | 3.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.0 | 7.0 | GO:0033263 | CORVET complex(GO:0033263) |
1.0 | 9.7 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 8.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 2.9 | GO:0071014 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.9 | 5.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.9 | 2.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.9 | 3.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.8 | 2.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.8 | 2.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 5.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 2.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.8 | 2.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 3.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 2.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 3.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.8 | 9.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.7 | 2.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 2.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 4.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 3.5 | GO:0033503 | HULC complex(GO:0033503) |
0.7 | 5.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 1.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.7 | 2.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.7 | 2.0 | GO:0005712 | chiasma(GO:0005712) |
0.7 | 6.7 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 5.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 2.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 3.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 2.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.6 | 6.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.6 | 4.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.6 | 18.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 3.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.6 | 4.1 | GO:0000243 | commitment complex(GO:0000243) |
0.6 | 11.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.6 | 6.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 2.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.6 | 0.6 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 23.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 2.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 7.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 2.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 3.2 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 4.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 14.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 2.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 1.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 1.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 7.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 4.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.5 | 3.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 1.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 4.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 1.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 2.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 1.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 2.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 4.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 1.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 3.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.5 | 1.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 0.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 0.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 0.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.4 | 1.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 5.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 4.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 1.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 3.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 1.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 2.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.4 | 9.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 3.1 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 0.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 1.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 2.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 3.0 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 5.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 3.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 3.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 2.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 3.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 1.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 3.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 6.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 1.3 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 1.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 9.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 1.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 3.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 8.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 4.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 4.3 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 6.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 4.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 5.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 10.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 1.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 1.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 9.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 2.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 2.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 12.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 1.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 2.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 14.9 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 3.1 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 1.9 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.3 | 1.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 2.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 4.9 | GO:0005903 | brush border(GO:0005903) |
0.3 | 3.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.6 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 4.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 2.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 2.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 2.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 1.0 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 2.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 2.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 20.8 | GO:0030496 | midbody(GO:0030496) |
0.2 | 5.0 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 10.5 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 2.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 5.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 12.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 4.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 2.1 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 3.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 2.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 6.3 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.7 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 3.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 2.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 7.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 1.4 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 10.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 2.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 2.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 10.4 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 4.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 3.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 4.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 3.2 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 9.8 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 22.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 1.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.5 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 2.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 5.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 2.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 2.5 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 3.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 1.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 11.7 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 11.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 1.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 3.7 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 0.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 3.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 6.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 51.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.3 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.2 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 2.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 7.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 2.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 3.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 5.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 3.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.5 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 3.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.7 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 3.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 9.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 120.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 15.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 5.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 24.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 49.7 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 2.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 84.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.8 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 8.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 3.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 3.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 2.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 4.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 3.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 2.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 3.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.5 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 3.8 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 1.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 2.4 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 141.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 10.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 2.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 25.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.8 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.0 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.0 | 1.2 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 2.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:1902911 | protein kinase complex(GO:1902911) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 3.8 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 2.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.8 | 11.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.6 | 10.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
2.2 | 6.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.0 | 7.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.9 | 5.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.8 | 5.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.6 | 4.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.6 | 4.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.5 | 6.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.5 | 5.9 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.5 | 10.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.4 | 9.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.4 | 4.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.4 | 5.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.4 | 4.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.3 | 4.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.3 | 3.9 | GO:0070905 | serine binding(GO:0070905) |
1.3 | 3.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.3 | 7.6 | GO:0031419 | cobalamin binding(GO:0031419) |
1.2 | 11.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.2 | 6.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 2.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.2 | 4.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.2 | 14.2 | GO:0048156 | tau protein binding(GO:0048156) |
1.1 | 4.6 | GO:0030984 | kininogen binding(GO:0030984) |
1.1 | 4.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.1 | 5.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.1 | 3.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.1 | 8.9 | GO:0008430 | selenium binding(GO:0008430) |
1.1 | 4.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 4.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.1 | 3.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.1 | 1.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.1 | 9.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.0 | 4.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.0 | 4.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.0 | 8.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.0 | 4.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.0 | 3.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.0 | 1.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.0 | 11.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.0 | 1.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.0 | 8.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.0 | 2.9 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.9 | 2.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.9 | 13.1 | GO:0010181 | FMN binding(GO:0010181) |
0.9 | 3.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.9 | 2.7 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.9 | 3.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.9 | 1.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.9 | 2.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 3.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.9 | 3.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 8.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.9 | 6.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 2.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.8 | 2.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.8 | 2.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.8 | 5.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 6.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.8 | 4.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 0.8 | GO:0035276 | ethanol binding(GO:0035276) |
0.8 | 3.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 2.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 3.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.8 | 3.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.8 | 3.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 4.5 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.7 | 1.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 2.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.7 | 14.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.7 | 2.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 5.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.7 | 5.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 5.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.7 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.7 | 3.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 2.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 1.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.7 | 2.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 2.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.7 | 2.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.7 | 1.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.7 | 0.7 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.7 | 2.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 2.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.7 | 2.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.7 | 4.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.7 | 4.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 10.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.7 | 12.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.6 | 1.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 2.6 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.6 | 3.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 2.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.6 | 14.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.6 | 1.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 5.7 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 3.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 2.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.6 | 3.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 8.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 5.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 6.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.6 | 1.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.6 | 3.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 2.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 6.0 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.6 | 1.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 18.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.6 | 2.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.6 | 5.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 1.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.6 | 1.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.6 | 8.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 4.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 3.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 1.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.6 | 1.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 1.7 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 3.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 1.7 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.6 | 2.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 1.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 4.4 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 15.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 2.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 4.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 2.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.5 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 2.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.5 | 5.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 1.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 17.7 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.5 | 2.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 3.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 4.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.5 | 2.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 2.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 8.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 1.0 | GO:0048038 | quinone binding(GO:0048038) |
0.5 | 2.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 3.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 3.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 2.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 16.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 1.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 4.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 2.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 3.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 1.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 2.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 0.5 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.5 | 1.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.5 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 1.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 1.4 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 1.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.5 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 2.3 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.5 | 2.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 2.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 4.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 1.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 2.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 3.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.7 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 1.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 3.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 17.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 1.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 13.1 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.4 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.4 | 0.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 1.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 1.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 3.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 2.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 0.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 5.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 1.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 1.7 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.4 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 0.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.4 | 2.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 0.4 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.4 | 1.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 3.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 0.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 3.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 2.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 0.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.4 | 2.7 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 1.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 8.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 1.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 1.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 1.9 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 4.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 8.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 12.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 1.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 1.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 1.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 4.5 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 2.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 2.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 3.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 0.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 5.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 2.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 1.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 2.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 1.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 2.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 0.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 3.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 5.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 1.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.4 | 1.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 3.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 3.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 1.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 3.1 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 1.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 6.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 4.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 4.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 0.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 6.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 18.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 1.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 3.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 2.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 2.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 4.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 31.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 1.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 2.6 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.3 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.3 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 9.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 6.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 4.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 5.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 7.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 6.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 0.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 1.6 | GO:0018632 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 1.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 3.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 2.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 0.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 1.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 10.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.5 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 1.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 1.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 3.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 15.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 2.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 4.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 0.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 1.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 8.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 4.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 3.0 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 4.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 2.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 4.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 2.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 3.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 0.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 1.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 11.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 1.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 1.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 4.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 2.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.3 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 29.5 | GO:0005506 | iron ion binding(GO:0005506) |
0.2 | 4.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 4.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.9 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 3.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 46.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.4 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 1.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 5.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 3.4 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 3.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 2.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.2 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.7 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 9.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 0.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 1.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 1.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 2.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 8.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 6.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 1.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 2.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 2.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 6.9 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 5.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 2.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 2.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 2.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 8.2 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 4.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 4.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.3 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 2.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 6.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 1.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 12.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.9 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.2 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 1.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 3.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 3.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 2.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 2.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 1.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 2.7 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 3.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 1.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 4.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 2.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 4.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.0 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 5.5 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 1.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 2.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 8.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.1 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 1.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 3.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.1 | GO:0003918 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 3.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 2.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 12.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 2.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 16.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.8 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 10.5 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 3.3 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 1.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.9 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 2.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 8.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 5.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 1.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 2.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 2.6 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.2 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 1.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 3.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 1.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 4.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.1 | 2.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 2.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.7 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 0.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 2.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 5.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 1.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 3.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 5.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 69.9 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.4 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 7.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 35.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 8.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.1 | GO:0005253 | anion channel activity(GO:0005253) |
0.1 | 0.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 1.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.2 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 1.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.4 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 1.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 2.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 1.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 4.4 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 1.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) SUMO binding(GO:0032183) |
0.0 | 13.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 3.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.7 | 23.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 1.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 18.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 14.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 6.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 13.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 8.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 13.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 2.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 2.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 28.9 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 7.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 6.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 3.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 1.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 17.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 17.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 3.1 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 27.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 7.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 1.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 20.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 4.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 5.7 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 3.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 6.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 9.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 7.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 1.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 3.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 12.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 6.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 5.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 8.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 6.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 11.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 11.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 2.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 10.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 4.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 8.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 5.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 6.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 3.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 4.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 10.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 7.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 7.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 3.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 6.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 5.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 7.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 2.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 0.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 5.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 1.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 4.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 5.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 3.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 3.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 6.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 3.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 8.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 2.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 11.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 12.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 8.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.3 | 13.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.2 | 17.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.2 | 33.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.0 | 13.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.0 | 2.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.0 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.9 | 14.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.9 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 9.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.8 | 7.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.8 | 12.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.8 | 1.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.8 | 8.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 15.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.7 | 7.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 14.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 6.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 17.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 18.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 11.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 1.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 7.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.6 | 0.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 1.7 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.6 | 5.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 9.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 9.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.5 | 9.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.5 | 6.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 4.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 9.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 6.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 6.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 4.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.5 | 4.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 5.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 2.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.4 | 4.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 5.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.4 | 10.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 7.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 0.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 4.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 14.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 21.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 8.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 3.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 4.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 3.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 5.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 1.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 2.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 1.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 5.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 4.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.4 | 3.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 3.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 1.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 6.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 7.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 3.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 3.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 0.3 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 3.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 12.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 0.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 3.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 8.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 2.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 3.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 5.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 5.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 1.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 5.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 5.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 4.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 4.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 3.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 5.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 5.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 2.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 7.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 2.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 15.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.3 | 6.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 1.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 6.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 3.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 9.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 12.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 9.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 2.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 15.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 4.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 10.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.2 | 21.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 3.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 1.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 2.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.4 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 7.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.7 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 4.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 6.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 3.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 4.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 7.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.4 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 1.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 2.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.3 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 4.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.0 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 0.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 1.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.6 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 2.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 2.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 1.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.4 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.3 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |